Brief: Verrica Pharmaceuticals Announces Acceptance Of Abstract Featuring Clinical Data Of VP-315
03/08/2023 14:55
Aug 3 (Reuters) - Verrica Pharmaceuticals Inc VRCA.O :
* VERRICA PHARMACEUTICALS ANNOUNCES ACCEPTANCE OF ABSTRACT
FEATURING CLINICAL DATA OF VP-315 FOR THE TREATMENT OF BASAL
CELL CARCINOMA AT THE AMERICAN ACADEMY OF DERMATOLOGY
ASSOCIATION’S (AAD) 2023 INNOVATION ACADEMY MEETING
Source text for Eikon: ID:nGNX3CCr26
Further company coverage: VRCA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Verrica Pharmaceuticals
See all newsVerrica Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Verrica Pharma reports wider-than-expected Q2 adj loss per share
Verrica Pharmaceuticals Inc expected to post a loss of 38 cents a share - Earnings Preview
Verrica Pharmaceuticals Q1 revenue rises on YCANTH demand
Brief: Verrica Pharmaceuticals Announces Upcoming Presentation Of Phase 2 Data